STAT3 and neoplasm: We suggest that the STAT3 could be likely activated in various pathways characterised by the activity of cytokines and growth factors, including interleukins IL-6, as previously noted in your study [29], but under leucine supplementation, this downstream protein could be reduced benefiting the skeletal muscle in these tumour-bearing animals (Fig. 4).